| NDC Code | 54092-701-04 |
|---|
| Package Description | 1 VIAL, GLASS in 1 BOX (54092-701-04) / 4 mL in 1 VIAL, GLASS |
|---|
| Product NDC | 54092-701 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Vpriv |
|---|
| Non-Proprietary Name | Velaglucerase Alfa |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20100226 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA022575 |
|---|
| Manufacturer | Takeda Pharmaceuticals America, Inc. |
|---|
| Substance Name | VELAGLUCERASE ALFA |
|---|
| Strength | 2.5 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
|---|